GlaxoSmithKline | GSK - Marktkapitalisierung

Aktienkurs
2,002.00
Täglich Wechseln
25.00 1.26%
Monatlich
-9.58%
Jährlich
34.72%
Q1 Prognose
1,909.93




Marktkapitalisierung Veränderung Datum
AbbVie USD 403.83B 5.2B 2025-12
Alcon AG USD 29.69B 1.39B 2026-03
Almirall EUR 2.43B 328.57M 2026-03
Amgen USD 176.25B 24.32B 2025-12
argenx SE USD 35.7B 16.14B 2026-03
AstraZeneca USD 220.14B 68B 2026-03
Bayer EUR 38.45B 2.09B 2026-03
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Fresenius EUR 28.24B 653.36M 2026-03
Fresenius Medical Care EUR 11.68B 275.81M 2026-03
Galapagos EUR 1.89B 49.73M 2026-03
Genmab DKK 105.72B 85.24B 2026-03
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Glaxosmithkline GBP 107.89B 7.96B 2026-03
GRIFOLS EUR 4.43B 3.06B 2026-03
Hikma Pharmaceutical USD 2.92B 1.72B 2026-03
Lonza CHF 34.33B 3.44B 2026-03
Merck EUR 47.3B 6B 2026-03
Merck USD 261.26B 51.62B 2025-12
Novartis USD 240.48B 51.73B 2026-03
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Orion EUR 8.94B 243.74M 2025-12
Pfizer USD 153.96B 12.4B 2026-03
Philips EUR 21.8B 579.27M 2026-03
Recordati EUR 9.25B 896.62M 2026-03
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Smith & Nephew USD 3.83B 9.49B 2026-03
UCB EUR 47.65B 1.24B 2026-03